23:28:10 EDT Thu 16 May 2024
Enter Symbol
or Name
USA
CA



Pangenomic Health Inc
Symbol NARA
Shares Issued 104,967,459
Close 2024-03-18 C$ 0.015
Market Cap C$ 1,574,512
Recent Sedar Documents

Pangenomic Health arranges 1:10 share rollback

2024-03-18 14:40 ET - News Release

Mr. Jerry Lai reports

PANGENOMIC HEALTH ANNOUNCES PROPOSED CONSOLIDATION AND COMPLETION OF WITHDRAWAL FROM AQSE

Pangenomic Health Inc. intends to consolidate all of its issued and outstanding Class A common shares on the basis of one postconsolidation common share for every 10 preconsolidation common shares.

There are currently 104,967,459 issued and outstanding. Upon completion of the consolidation, there are expected to be approximately 10,496,746 common shares issued and outstanding, subject to rounding of fractional common shares. No fractional common shares will be issued as a result of the consolidation. Fractional common shares equal to or greater than one-half will be rounded up to a whole number. Fractional common shares less than one-half will be cancelled without any repayment of capital or other compensation.

The common shares are expected to begin trading on a consolidated basis on the Canadian Securities Exchange on March 21, 2024. The record date for the consolidation is March 22, 2024. The consolidation is subject to approval by the CSE.

The new Cusip number for the postconsolidation common shares will be 69842E304 and the new ISIN (international securities identification number) will be CA69842E3041. The common shares will continue to trade on the CSE under the symbol NARA, and the company's name will not change.

Management of the company believes that the consolidation will provide the company with a share structure that will better attract future capital financing and enhance growth opportunities.

Withdrawal from Aquis Stock Exchange Growth Market (AQSE)

Further to the company's news release on Feb. 20, 2024, trading of the common shares on the AQSE ceased on March 15, 2024.

About Pangenomic Health Inc.

Pangenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The company's initial focus is to support mental health. Registered as a British Columbia benefit company, Pangenomic Health's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.